Immunohistochemical analysis of LRIG proteins in meningiomas: Correlation between estrogen receptor status and LRIG expression

Journal of Neuro-Oncology

Volumn 108, Issue 3, 2012, Pages 435-441

  Ghasimi, Soma ^a   Haapasalo, Hannu ^b   Eray, Mine ^b   Korhonen, Katariina ^c   Brännström, Thomas ^a   Hedman, Håkan ^a   Andersson, Ulrika ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Estrogen receptor; LRIG1; LRIG2; Meningiomas

Indexed keywords

ESTROGEN RECEPTOR; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; PROTEIN LRIG1; PROTEIN LRIG2; PROTEIN LRIG3; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84864067353     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0856-x     Document Type: Article

References (36)

1. Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307-314
2. Patil CG et al (2010) Craniotomy for resection of meningioma in the elderly: a multicentre, prospective analysis from the National Surgical Quality Improvement Program. J Neurol Neurosurg Psychiatry 81(5):502-505
3. Malmer B, Henriksson R, Gronberg H (2003) Familial brain tumours\-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106(2):260-263 (Pubitemid 36835180)
4. Preston DL et al (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94(20):1555-1563 (Pubitemid 35277279)
5. Umansky F et al (2008) Radiation-induced meningioma. Neuro-surg Focus 24(5):E7
6. Sadetzki S et al (2005) Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14(4):969-976 (Pubitemid 40478565)
7. Sadetzki S et al (2002) Radiation-induced meningioma: a descriptive study of253 cases. J Neurosurg 97(5):1078-1082 (Pubitemid 35253544)
8. Schoenberg BS, Christine BW, Whisnant JP (1975) Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25(8):705-712
9. Custer B et al (2006) Hormonal exposures and the risk of intra-cranial meningioma in women: a population-based case-control study. BMC Cancer 6:152
10. Guo D et al (2004) The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 84(1):157-165 (Pubitemid 38760139)
11. Holmlund C et al (2004) Characterization and tissue-specific expression of human LRIG2. Gene 332:35-43 (Pubitemid 38624248)
12. Nilsson J et al (2001) Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun 284(5):1155-1161 (Pubitemid 32917959)
13. Hedman H, Henriksson R (2007) LRIG inhibitors of growth factor signalling\-double-edged swords in human cancer? Eur J Cancer 43(4):676-682 (Pubitemid 46502902)
14. Karlsson T et al (2008) Redistribution of LRIG proteins in pso-riasis. J Invest Dermatol 128(5):1192-1195
15. Gur G et al (2004) LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 23(16):3270-3281 (Pubitemid 39209151)
16. Laederich MB et al (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem 279(45):47050-47056 (Pubitemid 39518360)
17. Yi W et al (2011) Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp Cell Res 317(4):504-512
18. Torp SH et al (1992) Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue. APMIS 100(9):797-802
19. Andersson U et al (2004) Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 108(2):135-142 (Pubitemid 39136299)
20. Wernicke AG et al (2010) Assessment ofepidermal growth factor receptor (EGFR) expression in human meningioma. Radiat Oncol 5:46. doi:10.1186/1748-717X- 5-46
21. Hedman H et al (2010) LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncol 49(6):812-815
22. Krig SR et al (2011) Lrig1 is an estrogen-regulated growth sup-pressor and correlates with longer relapse-free survival in ER{alpha}-positive breast cancer. Mol Cancer Res 9(10): 1406-1417
23. Tanemura A et al (2005) LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohisto-chemical analysis for 38 cases. Dermatol Surg 31(4):423-430 (Pubitemid 40489303)
24. Lindstrom AK et al (2008) LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer 18(2):312-317 (Pubitemid 351365217)
25. Thomasson M et al (2011) LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer 128(12):2843-2852
26. Guo D et al (2006) Perinuclear leucine-rich repeats and immu-noglobulin-like domain proteins (LRIG1-3) as prognostic indi-cators in astrocytic tumors. Acta Neuropathol 111(3):238-246
27. Holmlund C et al (2009) Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neu-ropathology 29(3):242-247
28. Korhonen K et al (2006) Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80(1):1-7 (Pubitemid 44473255)
29. Louis DN, Weistler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. WHO, Lyon
30. Kononen J et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844-847 (Pubitemid 28331029)
31. Nilsson J et al (2003) LRIG1 protein in human cells and tissues. Cell Tissue Res 312(1):65-71 (Pubitemid 36578847)
32. Michaud DS et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19(10):2562-2569
33. Korhonen K et al (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21(12):2149-2156
34. Leaes CG et al (2010) Immunohistochemical expression of aro-matase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30(1):44-49
35. Guevara P et al (2010) Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. J Neurooncol 98(3):379-384
36. Pravdenkova S et al (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105(2):163-173